SCM
ALNY icon

Sio Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Sio Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-36,632
Closed -$4.22M – 71
2019
Q4 		$4.22M Sell
36,632
-86,021
-70% -$8.58M 1% 27
2019
Q3 		$9.86M Sell
122,653
-28,900
-19% -$2.29M 3.18% 8
2019
Q2 		$11M Buy
151,553
+72,400
+91% +$5.55M 2.65% 9
2019
Q1 		$7.4M Sell
79,153
-75,484
-49% -$6.31M 2% 17
2018
Q4 		$11.3M Buy
154,637
+50,461
+48% +$3.88M 4.11% 3
2018
Q3 		$9.12M Buy
104,176
+74,341
+249% +$7.48M 3.13% 10
2018
Q2 		$2.94M Buy
+29,835
New +$2.96M 1.62% 26
2017
Q4 		– Sell
-20,225
Closed -$2.38M – 48
2017
Q3 		$2.38M Buy
+20,225
New +$1.73M 1.23% 29
2016
Q2 		– Sell
-153,778
Closed -$9.65M – 44
2016
Q1 		$9.65M Buy
+153,778
New +$10.2M 3.53% 11
2015
Q4 		– Sell
-64,996
Closed -$5.22M – 43
2015
Q3 		$5.22M Buy
64,996
+37,996
+141% +$4.22M 3.58% 11
2015
Q2 		$3.24M Buy
+27,000
New +$3.23M 1.6% 18

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Sio Capital Management's ALNY Position: Q1 2020 in Review

Sio Capital Management sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2020, closing a stake of 36,632 shares — an estimated $4.22M sold.

Sio Capital Management first reported a position in ALNY in Q2 2015 and held it in 11 quarters. The position peaked at $11.3M in Q4 2018. 331 funds tracked by Wall St. Rank hold ALNY as of Q1 2020.

  • Sio Capital Management reported no remaining Alnylam Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Sio Capital Management sold 36,632 Alnylam Pharmaceuticals shares in Q1 2020, an estimated $4.22M.
  • Sio Capital Management first reported a position in Alnylam Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Sio Capital Management's Alnylam Pharmaceuticals position peaked at $11.3M in Q4 2018.
  • 331 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2020.

Based on Sio Capital Management's 13F filing for Q1 2020, filed 15 May 2020.